• mail us help@24marketresearch.com
  • Int'l (+1)-646-781-7170
  • UK(Toll free) +44-800-088-5734

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Lysosomal Storage Diseases Therapeutics Market Size, Status and Forecast 2018-2025

Global Lysosomal Storage Diseases Therapeutics Market Size, Status and Forecast 2018-2025

  • Category:Life Sciences
  • Published on : 29 August 2018
  • Pages :93
  • Formats:
  • Report Code:24MRES-3055697
Click for best price

Best Price: $3120

This report focuses on the global Lysosomal Storage Diseases Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lysosomal Storage Diseases Therapeutics development in United States, Europe and China.

Lysosomal storage disorders is a group of genetic metabolic diseases caused by enzyme deficiencies in various body cells.
The Gaucher's Diseases indication segment is expected to be the most dominant segment in global lysosomal storage diseases therapeutics market.
Europe is estimated to be the dominant market in the global lysosomal storage diseases therapeutics market in 2017.
North America is expected to be the second most lucrative market in the global lysosomal storage diseases therapeutics market over the forecast period.
In 2017, the global Lysosomal Storage Diseases Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Shire
Pfizer
Sanofi
BioMarin Pharmaceutical
Actelion Ltd
Raptor Pharmaceutical
Protalix Biotherapeutics
Amicus Therapeutics

Market segment by Type, the product can be split into
Enzyme Replacement Therapy
Stem Cell Therapy
Substrate Reduction Therapy
Other

Market segment by Application, split into
Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Lysosomal Storage Diseases Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Lysosomal Storage Diseases Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Lysosomal Storage Diseases Therapeutics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENTS

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lysosomal Storage Diseases Therapeutics Market Size Growth Rate by Type (2013-2025)
1.4.2 Enzyme Replacement Therapy
1.4.3 Stem Cell Therapy
1.4.4 Substrate Reduction Therapy
1.4.5 Other
1.5 Market by Application
1.5.1 Global Lysosomal Storage Diseases Therapeutics Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Lysosomal Storage Diseases Therapeutics Market Size
2.2 Lysosomal Storage Diseases Therapeutics Growth Trends by Regions
2.2.1 Lysosomal Storage Diseases Therapeutics Market Size by Regions (2013-2025)
2.2.2 Lysosomal Storage Diseases Therapeutics Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Lysosomal Storage Diseases Therapeutics Market Size by Manufacturers
3.1.1 Global Lysosomal Storage Diseases Therapeutics Revenue by Manufacturers (2013-2018)
3.1.2 Global Lysosomal Storage Diseases Therapeutics Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Lysosomal Storage Diseases Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Lysosomal Storage Diseases Therapeutics Key Players Head office and Area Served
3.3 Key Players Lysosomal Storage Diseases Therapeutics Product/Solution/Service
3.4 Date of Enter into Lysosomal Storage Diseases Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Lysosomal Storage Diseases Therapeutics Market Size by Type (2013-2018)
4.2 Global Lysosomal Storage Diseases Therapeutics Market Size by Application (2013-2018)

5 United States
5.1 United States Lysosomal Storage Diseases Therapeutics Market Size (2013-2018)
5.2 Lysosomal Storage Diseases Therapeutics Key Players in United States
5.3 United States Lysosomal Storage Diseases Therapeutics Market Size by Type
5.4 United States Lysosomal Storage Diseases Therapeutics Market Size by Application

6 Europe
6.1 Europe Lysosomal Storage Diseases Therapeutics Market Size (2013-2018)
6.2 Lysosomal Storage Diseases Therapeutics Key Players in Europe
6.3 Europe Lysosomal Storage Diseases Therapeutics Market Size by Type
6.4 Europe Lysosomal Storage Diseases Therapeutics Market Size by Application

7 China
7.1 China Lysosomal Storage Diseases Therapeutics Market Size (2013-2018)
7.2 Lysosomal Storage Diseases Therapeutics Key Players in China
7.3 China Lysosomal Storage Diseases Therapeutics Market Size by Type
7.4 China Lysosomal Storage Diseases Therapeutics Market Size by Application

8 Japan
8.1 Japan Lysosomal Storage Diseases Therapeutics Market Size (2013-2018)
8.2 Lysosomal Storage Diseases Therapeutics Key Players in Japan
8.3 Japan Lysosomal Storage Diseases Therapeutics Market Size by Type
8.4 Japan Lysosomal Storage Diseases Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Lysosomal Storage Diseases Therapeutics Market Size (2013-2018)
9.2 Lysosomal Storage Diseases Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Lysosomal Storage Diseases Therapeutics Market Size by Type
9.4 Southeast Asia Lysosomal Storage Diseases Therapeutics Market Size by Application

10 India
10.1 India Lysosomal Storage Diseases Therapeutics Market Size (2013-2018)
10.2 Lysosomal Storage Diseases Therapeutics Key Players in India
10.3 India Lysosomal Storage Diseases Therapeutics Market Size by Type
10.4 India Lysosomal Storage Diseases Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Lysosomal Storage Diseases Therapeutics Market Size (2013-2018)
11.2 Lysosomal Storage Diseases Therapeutics Key Players in Central & South America
11.3 Central & South America Lysosomal Storage Diseases Therapeutics Market Size by Type
11.4 Central & South America Lysosomal Storage Diseases Therapeutics Market Size by Application

12 International Players Profiles
12.1 Shire
12.1.1 Shire Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lysosomal Storage Diseases Therapeutics Introduction
12.1.4 Shire Revenue in Lysosomal Storage Diseases Therapeutics Business (2013-2018)
12.1.5 Shire Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lysosomal Storage Diseases Therapeutics Introduction
12.2.4 Pfizer Revenue in Lysosomal Storage Diseases Therapeutics Business (2013-2018)
12.2.5 Pfizer Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lysosomal Storage Diseases Therapeutics Introduction
12.3.4 Sanofi Revenue in Lysosomal Storage Diseases Therapeutics Business (2013-2018)
12.3.5 Sanofi Recent Development
12.4 BioMarin Pharmaceutical
12.4.1 BioMarin Pharmaceutical Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lysosomal Storage Diseases Therapeutics Introduction
12.4.4 BioMarin Pharmaceutical Revenue in Lysosomal Storage Diseases Therapeutics Business (2013-2018)
12.4.5 BioMarin Pharmaceutical Recent Development
12.5 Actelion Ltd
12.5.1 Actelion Ltd Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lysosomal Storage Diseases Therapeutics Introduction
12.5.4 Actelion Ltd Revenue in Lysosomal Storage Diseases Therapeutics Business (2013-2018)
12.5.5 Actelion Ltd Recent Development
12.6 Raptor Pharmaceutical
12.6.1 Raptor Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Lysosomal Storage Diseases Therapeutics Introduction
12.6.4 Raptor Pharmaceutical Revenue in Lysosomal Storage Diseases Therapeutics Business (2013-2018)
12.6.5 Raptor Pharmaceutical Recent Development
12.7 Protalix Biotherapeutics
12.7.1 Protalix Biotherapeutics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Lysosomal Storage Diseases Therapeutics Introduction
12.7.4 Protalix Biotherapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2013-2018)
12.7.5 Protalix Biotherapeutics Recent Development
12.8 Amicus Therapeutics
12.8.1 Amicus Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Lysosomal Storage Diseases Therapeutics Introduction
12.8.4 Amicus Therapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2013-2018)
12.8.5 Amicus Therapeutics Recent Development

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

LIST OF TABLES & FIGURES

List of Tables and Figures

Table Lysosomal Storage Diseases Therapeutics Key Market Segments
Table Key Players Lysosomal Storage Diseases Therapeutics Covered
Table Global Lysosomal Storage Diseases Therapeutics Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size Market Share by Type 2013-2025
Figure Enzyme Replacement Therapy Figures
Table Key Players of Enzyme Replacement Therapy
Figure Stem Cell Therapy Figures
Table Key Players of Stem Cell Therapy
Figure Substrate Reduction Therapy Figures
Table Key Players of Substrate Reduction Therapy
Figure Other Figures
Table Key Players of Other
Table Global Lysosomal Storage Diseases Therapeutics Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Lysosomal Storage Diseases Therapeutics Report Years Considered
Table Global Lysosomal Storage Diseases Therapeutics Market Size 2013-2025 (Million US$)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Lysosomal Storage Diseases Therapeutics Market Size by Regions 2013-2025 (Million US$)
Table Global Lysosomal Storage Diseases Therapeutics Market Size by Regions 2013-2018 (Million US$)
Table Global Lysosomal Storage Diseases Therapeutics Market Share by Regions 2013-2018
Figure Global Lysosomal Storage Diseases Therapeutics Market Share by Regions 2013-2018
Figure Global Lysosomal Storage Diseases Therapeutics Market Share by Regions 2018
Table Market Top Trends
Table Global Lysosomal Storage Diseases Therapeutics Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Lysosomal Storage Diseases Therapeutics Market Share by Manufacturers (2013-2018)
Figure Global Lysosomal Storage Diseases Therapeutics Market Share by Manufacturers in 2018
Table Global Lysosomal Storage Diseases Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Lysosomal Storage Diseases Therapeutics Product/Solution/Service
Table Date of Enter into Lysosomal Storage Diseases Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Lysosomal Storage Diseases Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Global Lysosomal Storage Diseases Therapeutics Market Size Share by Type (2013-2018)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size Market Share by Type (2013-2018)
Table Global Lysosomal Storage Diseases Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Global Lysosomal Storage Diseases Therapeutics Market Size Share by Application (2013-2018)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global Lysosomal Storage Diseases Therapeutics Revenue Market Share by Application in 2017
Figure United States Lysosomal Storage Diseases Therapeutics Market Size 2013-2018 (Million US$)
Table United States Key Players Lysosomal Storage Diseases Therapeutics Revenue (2017-2018) (Million US$)
Table United States Key Players Lysosomal Storage Diseases Therapeutics Market Share (2017-2018)
Table United States Lysosomal Storage Diseases Therapeutics Market Size by Type (2013-2018) (Million US$)
Table United States Lysosomal Storage Diseases Therapeutics Market Share by Type (2013-2018)
Table United States Lysosomal Storage Diseases Therapeutics Market Size by Application (2013-2018) (Million US$)
Table United States Lysosomal Storage Diseases Therapeutics Market Share by Application (2013-2018)
Figure Europe Lysosomal Storage Diseases Therapeutics Market Size 2013-2018 (Million US$)
Table Europe Key Players Lysosomal Storage Diseases Therapeutics Revenue (2017-2018) (Million US$)
Table Europe Key Players Lysosomal Storage Diseases Therapeutics Market Share (2017-2018)
Table Europe Lysosomal Storage Diseases Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Europe Lysosomal Storage Diseases Therapeutics Market Share by Type (2013-2018)
Table Europe Lysosomal Storage Diseases Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Europe Lysosomal Storage Diseases Therapeutics Market Share by Application (2013-2018)
Figure China Lysosomal Storage Diseases Therapeutics Market Size 2013-2018 (Million US$)
Table China Key Players Lysosomal Storage Diseases Therapeutics Revenue (2017-2018) (Million US$)
Table China Key Players Lysosomal Storage Diseases Therapeutics Market Share (2017-2018)
Table China Lysosomal Storage Diseases Therapeutics Market Size by Type (2013-2018) (Million US$)
Table China Lysosomal Storage Diseases Therapeutics Market Share by Type (2013-2018)
Table China Lysosomal Storage Diseases Therapeutics Market Size by Application (2013-2018) (Million US$)
Table China Lysosomal Storage Diseases Therapeutics Market Share by Application (2013-2018)
Figure Japan Lysosomal Storage Diseases Therapeutics Market Size 2013-2018 (Million US$)
Table Japan Key Players Lysosomal Storage Diseases Therapeutics Revenue (2017-2018) (Million US$)
Table Japan Key Players Lysosomal Storage Diseases Therapeutics Market Share (2017-2018)
Table Japan Lysosomal Storage Diseases Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Japan Lysosomal Storage Diseases Therapeutics Market Share by Type (2013-2018)
Table Japan Lysosomal Storage Diseases Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Japan Lysosomal Storage Diseases Therapeutics Market Share by Application (2013-2018)
Figure Southeast Asia Lysosomal Storage Diseases Therapeutics Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Lysosomal Storage Diseases Therapeutics Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Lysosomal Storage Diseases Therapeutics Market Share (2017-2018)
Table Southeast Asia Lysosomal Storage Diseases Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Lysosomal Storage Diseases Therapeutics Market Share by Type (2013-2018)
Table Southeast Asia Lysosomal Storage Diseases Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Lysosomal Storage Diseases Therapeutics Market Share by Application (2013-2018)
Figure India Lysosomal Storage Diseases Therapeutics Market Size 2013-2018 (Million US$)
Table India Key Players Lysosomal Storage Diseases Therapeutics Revenue (2017-2018) (Million US$)
Table India Key Players Lysosomal Storage Diseases Therapeutics Market Share (2017-2018)
Table India Lysosomal Storage Diseases Therapeutics Market Size by Type (2013-2018) (Million US$)
Table India Lysosomal Storage Diseases Therapeutics Market Share by Type (2013-2018)
Table India Lysosomal Storage Diseases Therapeutics Market Size by Application (2013-2018) (Million US$)
Table India Lysosomal Storage Diseases Therapeutics Market Share by Application (2013-2018)
Figure Central & South America Lysosomal Storage Diseases Therapeutics Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Lysosomal Storage Diseases Therapeutics Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Lysosomal Storage Diseases Therapeutics Market Share (2017-2018)
Table Central & South America Lysosomal Storage Diseases Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Central & South America Lysosomal Storage Diseases Therapeutics Market Share by Type (2013-2018)
Table Central & South America Lysosomal Storage Diseases Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Central & South America Lysosomal Storage Diseases Therapeutics Market Share by Application (2013-2018)
Table Shire Company Details
Table Shire Revenue in Lysosomal Storage Diseases Therapeutics Business (2013-2018) (Million US$)
Figure Shire Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2013-2018)
Table Shire Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Lysosomal Storage Diseases Therapeutics Business (2013-2018)(Million US$)
Figure Pfizer Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2013-2018)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Lysosomal Storage Diseases Therapeutics Business (2013-2018)(Million US$)
Figure Sanofi Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2013-2018)
Table Sanofi Recent Development
Table BioMarin Pharmaceutical Company Details
Table BioMarin Pharmaceutical Revenue in Lysosomal Storage Diseases Therapeutics Business (2013-2018)(Million US$)
Figure BioMarin Pharmaceutical Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2013-2018)
Table BioMarin Pharmaceutical Recent Development
Table Actelion Ltd Company Details
Table Actelion Ltd Revenue in Lysosomal Storage Diseases Therapeutics Business (2013-2018)(Million US$)
Figure Actelion Ltd Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2013-2018)
Table Actelion Ltd Recent Development
Table Raptor Pharmaceutical Company Details
Table Raptor Pharmaceutical Revenue in Lysosomal Storage Diseases Therapeutics Business (2013-2018)(Million US$)
Figure Raptor Pharmaceutical Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2013-2018)
Table Raptor Pharmaceutical Recent Development
Table Protalix Biotherapeutics Company Details
Table Protalix Biotherapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2013-2018)(Million US$)
Figure Protalix Biotherapeutics Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2013-2018)
Table Protalix Biotherapeutics Recent Development
Table Amicus Therapeutics Company Details
Table Amicus Therapeutics Revenue in Lysosomal Storage Diseases Therapeutics Business (2013-2018)(Million US$)
Figure Amicus Therapeutics Revenue Growth Rate in Lysosomal Storage Diseases Therapeutics Business (2013-2018)
Table Amicus Therapeutics Recent Development
Table Global Lysosomal Storage Diseases Therapeutics Market Size by Regions (Million US$) 2018-2025
Figure Global Lysosomal Storage Diseases Therapeutics Market Size Share by Regions (2018-2025)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size Share by Regions in 2025
Figure United States Lysosomal Storage Diseases Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Europe Lysosomal Storage Diseases Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure China Lysosomal Storage Diseases Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Japan Lysosomal Storage Diseases Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Lysosomal Storage Diseases Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure India Lysosomal Storage Diseases Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Lysosomal Storage Diseases Therapeutics Market Size Forecast (2018-2025)(Million USD)
Table Global Lysosomal Storage Diseases Therapeutics Market Size by Product (2018-2025) (Million US$)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size by Product (2018-2025)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size by Product in 2025
Table Global Lysosomal Storage Diseases Therapeutics Market Size by Application (2018-2025) (Million US$)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size by Application (2018-2025)
Figure Global Lysosomal Storage Diseases Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

SELECT A FORMAT

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy
check discount
  BENCHMARKS  
Loading Time: Base Classes  0.0096
Controller Execution Time ( Reports Controller / Report Details )  4.8888
Total Execution Time  4.8995
  GET DATA  
No GET data exists
  MEMORY USAGE  
1,207,240 bytes
  POST DATA  
No POST data exists
  URI STRING  
life-sciences/3055697/global-lysosomal-storage-diseases-therapeutics-2018-2025-832
  CLASS/METHOD  
Reports_controller/report_details
  DATABASE:  chemical_common24 (Reports_controller:$db)   QUERIES: 12 (4.8679 seconds)  (Hide)
0.0001   SELECT GET_LOCK('38971a7bf5457417f8635706bcdde542'300) AS ci_session_lock 
0.0189   SELECT `data`
FROM `24mresearch_ci_sessions`
WHERE `id` = 'a225cb582508f2fd6808d567dbafe74b59cd805b' 
0.0004   SELECT `24_report`.*, `24_sub_cat_1`.`sc1_name`, `24_sub_cat_1`.`sc1_url`, `24_sub_cat_1`.`sc1_status`, `24_publisher`.`publisher_name`, `24_report_metadata`.*
FROM `24_report`
LEFT JOIN `24_sub_cat_1ON `24_sub_cat_1`.`sc1_id` = `24_report`.`rep_sub_cat_1_id`
LEFT JOIN `24_publisherON `24_publisher`.`publisher_id` = `24_report`.`publisher_id`
LEFT JOIN `24_report_metadataON `24_report_metadata`.`meta_rep_id` = `24_report`.`rep_id`
WHERE `rep_status` = 'Y'
AND `rep_archive_status` = 'N'
AND `rep_date` > '2017-03-31'
AND `24_report`.`rep_id` = '3055697' 
0.0001   SELECT `sc1_id`, `sc1_url`, `sc1_name`
FROM `24_sub_cat_1`
WHERE `sc1_status` = 'Y'
ORDER BY `sc1_idAS
0.0001   SELECT *
FROM `24_report_license`
WHERE `li_rep_id` = '3055697'
AND `li_pub_id` = '1' 
4.8477   SELECT `24_report`.`rep_title`, `24_report`.`rep_id`, `24_report`.`rep_url`, `24_report`.`rep_date`, `24_sub_cat_1`.`sc1_url`, `24_sub_cat_1`.`sc1_name`
FROM `24_report`
LEFT JOIN `24_sub_cat_1ON `24_report`.`rep_sub_cat_1_id`=`24_sub_cat_1`.`sc1_id`
WHERE `rep_status` = 'Y'
AND `rep_archive_status` = 'N'
AND `rep_date` > '2017-03-31'
AND  `rep_titleLIKE '%lysosomal storage diseases therapeutics%' ESCAPE '!'
 
LIMIT 4 
0.0002   SELECT FROM 24_report_currency WHERE cur_symbol 'GBP' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'EUR' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'JPY' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'GBP' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'EUR' 
0.0000   SELECT FROM 24_report_currency WHERE cur_symbol 'JPY' 
  HTTP HEADERS  (Show)
  SESSION DATA  (Show)
  CONFIG VARIABLES  (Show)